We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cancer Genome Analysis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2011 by Seoul National University Hospital.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01458704
First Posted: October 25, 2011
Last Update Posted: October 25, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Seoul National University Hospital
  Purpose
Next generation sequencing (including targeted gene seqeuncing, exome and transcriptome sequencing) will be performed from fresh frozen tumor samples to understand the genetic alteration of tumors and to aid in optimal selection of further therapeutic agents.

Condition Intervention
Malignant Tumor Other: next generation sequencing

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Cancer Genome Analysis

Further study details as provided by Seoul National University Hospital:

Primary Outcome Measures:
  • targeted sequencing of cancer-relate genes [ Time Frame: 1 year ]
    Identification and characterization of genetic alteration in cancer tissue


Biospecimen Retention:   Samples With DNA
fresh frozen tumor tissue

Estimated Enrollment: 100
Study Start Date: August 2011
Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
fresh frozen tumor tissue
patients providing fresh frozen tumor tissue
Other: next generation sequencing
next generation sequencing (including targeted gene sequencing, exome sequencing, transcriptome sequenicing)

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with malignant tumor receiving or planning to receive chemotherapy with fresh frozen tumor tissue with informed consent
Criteria

Inclusion Criteria:

  • patients with malignant tumor
  • receiving or planning to receive chemotherapy
  • with fresh frozen tumor tissue
  • with informed consent
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01458704


Contacts
Contact: Tae-You Kim 82-2-2072-2228

Locations
Korea, Republic of
Seoul National University Hospital Recruiting
Seoul, Korea, Republic of, 110-744
Contact: Tae-You Kim    82-2-2072-2228    kimty@snu.ac.kr   
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Principal Investigator: Tae-You Kim Seoul National University Hospital
  More Information

Responsible Party: Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT01458704     History of Changes
Other Study ID Numbers: Cancer genome analysis
First Submitted: October 23, 2011
First Posted: October 25, 2011
Last Update Posted: October 25, 2011
Last Verified: October 2011

Additional relevant MeSH terms:
Neoplasms